Literature DB >> 47756

Large peptides of bovine and guinea pig myelin basic proteins produced by limited peptic hydrolysis.

R E Martenson, A J Kramer, G E Deibler.   

Abstract

Bovine and guinea pig myelin basic proteins were cleaved with pepsin at pH 3.0 or pH 6.0 (enzyme/substrate, 1:500, w/w), and the peptides were isolated and identified. At pH 3.0 cleavage of the bovine protein occurred principally at three sites: Phe-Phe (88-89), Phe-Phe (42-43), and Leu-Asp (36-37). Minor cleavages occurred at Leu-Ser (110-111), Phe-Ser (113-114), and Ile-Phe (152-153). A study of the time course of the hydrolysis showed that the reaction was biphasic; nearly all of the protein was cleaved at Phe-Phe (88-89) before significant cleavages at other sites occurred. At pH 6.0 cleavage of the bovine protein occurred almost exclusively at a single site, the Phe-Phe bond at position 88-89, resulting in bisection of the protein. Treatment of the guinea pig protein with pepsin under the same conditions resulted in the production of peptides which were identical with those of the bovine protein in chromatographic and electrophoretic properties and in N-terminal and C-terminal residues but which differed slightly in amino acid composition.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 47756     DOI: 10.1021/bi00676a029

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  3 in total

1.  Myelin basic protein in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases.

Authors:  A Biber; D Englert; D Dommasch; K Hempel
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

2.  Enzymatic and nonenzymatic degradation of myelin basic protein.

Authors:  G E Deibler; L F Boyd; M W Kies
Journal:  Neurochem Res       Date:  1984-10       Impact factor: 3.996

3.  Immune response of Lewis rats to peptide C1 (residues 68-88) of guinea pig and rat myelin basic proteins.

Authors:  R F Kibler; R B Fritz; F Chou; N Y Peacocke; N M Brown; D E McFarlin
Journal:  J Exp Med       Date:  1977-11-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.